Stockreport

Pfizer, Astellas first-line bladder cancer therapy accepted for review in China [Seeking Alpha]

Pfizer, Inc.  (PFE) 
Last pfizer, inc. earnings: 4/28 06:45 am Check Earnings Report
PDF conjugate it co-develops with Pfizer ( NYSE: PFE ), as a first-line option for certain patients with bladder cancer. On Wednesday, China's Center for Drug Evaluation a [Read more]